Solstice raises $21.0M Series A (United States, May 2026)

$21.0M
$21M
Generated social card
Solstice social card
Headline

AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days - Tech Funding News

About

Solstice is an AI-native pharma marketing startup that aims to streamline the marketing and regulatory review processes for pharmaceutical companies. By leveraging AI technology, it significantly reduces the time required for campaign approvals, allowing companies to launch marketing campaigns in as little as 10 days. The startup has already partnered with several top pharmaceutical brands to enhance their marketing efficiency.

Article summary

AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days  Tech Funding News

Founder
Yiwen Li
Yiwen Li
Co-founder
Investors · 3
1 hidden
Transformation CapitalLead
FUND
Twelve Below
FUND
Related rounds
Jul 05, 2026Venice$65.0MSeries AUnited States
Jul 04, 2026Pillar$20.0MSeedUnited States
Jul 04, 2026Simile$100.0MUnited States
Jul 03, 2026AWS$1.00BUnited States